Clinical Trials Directory

Trials / Completed

CompletedNCT05459883

Splenic Artery Ligation and Portocaval Shunt in Small-for-size Syndrome

Hemodynamic Modulations to Ameliorate Sinusoidal Injuries After Extended Liver Resections: the Role of Splenic Artery Ligation and Porto-caval Shunt in a Series of Patients

Status
Completed
Phase
Study type
Observational
Enrollment
13 (actual)
Sponsor
Aretaieion University Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Our study aimed at assessing the changes of portal vein pressure, portal vein flow and hepatic arterial flow (HAF) in liver remnants ≤ 30% of the standard liver volume by reducing portal vein overflow via ligation of the splenic artery.

Detailed description

It has been reported that prevention of acute portal overpressure in small-for-size liver grafts leads to better postoperative outcomes. Accordingly, we aimed to investigate the feasibility of the technique of splenic artery ligation in a case series of patients subjected to major liver resections with evidence of small-for-size syndrome and whether the maneuver results in reduction of portal venous pressure and flow.

Conditions

Interventions

TypeNameDescription
PROCEDUREsplenic artery ligationWe identified portal hyperperfusion as a cause of potential small-for-size liver remnant dysfunction and we applied splenic artery ligation as a technically simple procedure to manage the situation

Timeline

Start date
2017-01-01
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2022-07-15
Last updated
2022-07-15

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT05459883. Inclusion in this directory is not an endorsement.